Sequoia-Backed Betta Pharma Completes $106M IPO In China’s ChiNext Board

Login to View

Betta Pharmaceuticals Co., Ltd., backed by Sequoia Capital China and other investors, has completed an initial public offering on the Shenzhen Stock Exchange’s NASDAQ-style ChiNext Board, raising RMB720 million (US$106 million).

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in